Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma-Reference-Cited by-同舟云学术

Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma

Published:2018-03-29 Issue:13 Volume:378 Page:1211-1223
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Tam Constantine S.¹,Anderson Mary Ann¹,Pott Christiane¹,Agarwal Rishu¹,Handunnetti Sasanka¹,Hicks Rodney J.¹,Burbury Kate¹,Turner Gillian¹,Di Iulio Juliana¹,Bressel Mathias¹,Westerman David¹,Lade Stephen¹,Dreyling Martin¹,Dawson Sarah-Jane¹,Dawson Mark A.¹,Seymour John F.¹,Roberts Andrew W.¹

Affiliation:

1. From the Peter MacCallum Cancer Centre, Melbourne, VIC (C.S.T., M.A.A., R.A., S.H., R.J.H., K.B., G.T., J.D.I., M.B., D.W., S.L., S.-J.D., M.A.D., J.F.S., A.W.R.), and the Victorian Comprehensive Cancer Centre (C.S.T., M.A.A., R.A., S.H., R.J.H., K.B., D.W., S.-J.D., M.A.D., J.F.S., A.W.R.), the Faculty of Medicine (C.S.T., R.J.H., S.-J.D., M.A.D., J.F.S., A.W.R.) and Centre for Cancer Research (S.-J.D., M.A.D.), University of Melbourne, the Department of Clinical Haematology and Bone Marrow...

Funder

Victorian Cancer Agency

Leukemia and Lymphoma Society

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1715519

Cited by 340 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful treatment with PR-mini-CHP for elderly relapsed and refractory mantle cell lymphoma;2024-09-03

2. Dismantling relapsed/refractory mantle cell lymphoma;Blood Reviews;2024-09

3. Acalabrutinib plus venetoclax and rituximab in treatment-naive mantle cell lymphoma: 2-year safety and efficacy analysis;Blood Advances;2024-08-29

4. Ready, AIM, stop: ibrutinib plus venetoclax in MCL;Blood;2024-08-22

5. Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions;Blood;2024-08-22